TABLE 6.
Five most frequently cited articles in CMR, 1994 to 1997a,b
| Yr | First author | Topic |
|---|---|---|
| 1994 | R. Weberc | Human microsporidial infections |
| A. van Belkumc | DNA fingerprinting of microorganisms by PCR | |
| W. E. Kloos | Clinical significance of coagulase-negative staphylococci | |
| M. K. Hostetter | Candida sp. interaction with epithelial and endothelial surfaces | |
| O. Olsvik | Magnetic separation techniques in diagnostic microbiology | |
| 1995 | N. Woodford | Current perspectives on glycopeptide resistance |
| D. M. Livermore | β-Lactamases in laboratory and clinical resistance | |
| T. G. Mitchell | Cryptococcosis in the era of AIDS | |
| E. De Clercq | Antiviral therapy for human immunodeficiency virus infections | |
| C.-C. Kuo | Chlamydia pneumoniae (TWAR) | |
| 1996 | E. Bergogne-Bérézin | Acinetobacter spp. as nosocomial pathogens |
| J. O. Falkinham | Epidemiology of infection by nontuberculous mycobacteria | |
| D. N. Fredricks | Sequence-based identification of microbial pathogens | |
| S. K. Fridkin | Epidemiology of nosocomial fungal infections | |
| D. R. Lucey | Type 1 and type 2 cytokine dysregulation in human diseases | |
| 1997 | G. Funke | Clinical microbiology of coryneform bacteria |
| R. D. Perry | Yersinia pestis—etiologic agent of plague | |
| C. M. Black | Laboratory diagnosis of Chlamydia trachomatis infections | |
| B. E. Dunn | Helicobacter pylori | |
| R. A. Miller | Role of oxidants in microbial pathophysiology |